Company profile
First Tracks Biotherapeutics, Inc. Insider Trading
TRAXEvery SEC Form 4 insider trading filing for First Tracks Biotherapeutics, Inc. (TRAX) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0002091349
- Filings
- 41
- Insiders
- 12
- Last filing
- 2026-09-15
Activity summary
Recent insider activity is bullish. Over the last 30 days, 5 insiders purchased shares versus 1 sale. Buying was led by J. Anthony Ware.
Quarterly balance
Buy and sell value by quarter, Q2 26 to Q3 26. First Tracks Biotherapeutics, Inc. insiders were net sellers in every quarter shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $65.0M.
90 day insight
Over the last 90 days, First Tracks Biotherapeutics, Inc. insiders bought $225K (11 transactions) and sold $1.8M (1 transaction).
- Most active insider: J. Anthony Ware with 4 transactions totaling $2.0M.
- Largest single sale: $1.8M by J. Anthony Ware on Sep 2, 2026.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | John A Orwin | TRAX | Option Exercise | 1,300 | — | — |
| Sep 15, 2026 | John A Orwin | TRAX | Option Exercise | 1,300 | — | — |
| Sep 2, 2026 | J. Anthony Ware | TRAX | Option Exercise | 39,265 | $5.74 | $225K |
| Sep 2, 2026 | J. Anthony Ware | TRAX | Sale | 39,265 | $44.78 | $1.76M |
| Sep 2, 2026 | J. Anthony Ware | TRAX | Option Exercise | 28,571 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TRAX" \
-H "X-Api-Key: $KEY"